Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-02

Clinical Trial Update: Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS) [NA]

View source ↗

Summary

A completed clinical trial comparing intravenous immunoglobulin (IVIG) with plasma exchange (PE) in ventilated children with Guillain-Barré syndrome; the update…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Mansoura University Children Hospital | Conditions: Guillain Barre Syndrome | NA | Status: COMPLETED